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Tanya Johns1,2 and Bernard G Jaar1,2,3,4*Abstract
The burden of chronic kidney disease (CKD) is substantial and is associated with poor health outcomes including
increase hospitalizations and premature deaths, as well as considerable health care cost. In recognition of this
mounting public health problem, the U.S. Centers for Disease Control and Prevention and their collaborators
created a national CKD surveillance system. This commentary introduces the national CKD surveillance system and
discusses some of its potential uses.
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The burden of chronic kidney disease (CKD) is sub-
stantial, and is expected to rise. CKD, as defined by a
glomerular filtration rate of < 60 ml/min/1.73 m2, is
prevalent in 14% of the U.S. population, or 44 million
individuals [1]. Kidney disease consistently ranks among
the top 10 causes of death, and individuals with CKD
are also at increased risk of hospitalizations and cardio-
vascular events [1,2]. In recognition of this mounting
public health problem, the U.S. Centers for Disease
Control and Prevention (CDC) was congressionally
mandated to implement a national CKD surveillance
system. Although a federally funded surveillance system
for end-stage renal disease has existed for decades (the
United States Renal Data System) there was no cor-
responding monitoring system for CKD. The CDC
partnered with well-established researchers in CKD
epidemiology from the University of Michigan and the
University of California at San Francisco to design and
support such a system. The launch of this website (www.
cdc.gov/ckd) is timely; prior to this, there was no single
place to find detailed and comprehensive information on
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reproduction in any medium, provided the orThe surveillance system focuses on five topics or indi-
cators in CKD in addition to describing its prevalence
and incidence: 1) awareness, 2) risk factors, 3) health
consequences, 4) process and quality of care, and
5) healthcare system capacity. These indicators are in
line with those of Healthy People 2020, which are
evidence-based, 10-year, national objectives for impro-
ving health of all Americans, put forth by the U.S.
Department of Health and Human Services [3]. The
10-year goals include reducing the number of new cases
of CKD and its complications, disability, death, and eco-
nomic burden. Furthermore, the surveillance website
features a section that is dedicated to tracking the pro-
gress towards meeting the Healthy People 2020 CKD
objectives.Resource for general public, patients and health
providers
The information on the website is available to everyone
with the expectation that it will become an essential
resource on CKD. The website is designed to be user-
friendly and easy-to-navigate for the general public. The
information on the site is presented in a number of dif-
ferent formats including maps, figures, charts, sum-
maries, and videos. The CDC, in addition, creates and
disseminates a consensus document, the National CKD
Fact Sheet, which provides a concise overview on the
burden of CKD. Although much of the information mayral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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material is especially relevant to patients with CKD and
their health care providers. For example, there is a section
dedicated to describing the burden of established risk fac-
tors among patients with CKD. Patients and their pro-
viders may also find the health consequences indicator
germane, as it addresses some of the more common
comorbidities associated with advanced CKD. Risk factor
modification and the potential health consequences of
chronic kidney disease are two fundamental areas of CKD
education, and physicians, particularly primary care pro-
viders and nephrologists, should be well versed in these
data to have informed discussions with their patients. The
information on the website, however, may serve as a
reliable adjunct to the patient education that usually takes
place in the office or at the bedside. The site also has
videos that deal with important topics in kidney disease.
For example, one of the featured videos pertains to the
use of non-steroidal anti-inflammatory drugs (many of
them available over the counter in the United States) — a
practice that should be avoided in patients with CKD
(with the notable exception of aspirin for cardiovascular
disease protection). Unfortunately, a significant number of
patients continue to take these medications because they
may be unaware of the damaging consequences, or their
physicians overlooked their kidney disease. The website
also contains information pertinent to special populations,
namely children and solid organ transplant recipients with
chronic kidney disease. Health care providers and policy
makers may find the content on the processes to improve
quality and delivery of care particularly significant. In
creating this surveillance system, the CDC and their col-
laborators envisioned that it would lead to measurable im-
provement in the burden of CKD and quality of CKD
care. The surveillance website while inclusive is not the
only resource for important CKD information for patients
and health care providers. The American Board of In-
ternal Medicine in partnership with Consumer Reports re-
cently invited a number of medical societies including the
American Society of Nephrology to identify “Five Things
to Question” as part of their Choosing Wisely initiative.
These five questions pertain to test and procedures that
are commonly done in patients with CKD, which may be
unnecessary or potentially harmful and should be pre-
ceded by a thorough risk benefit discussion with the pa-
tient and their family. For example, the common practice
of using peripherally inserted central catheters in patients
with CKD could lead to difficulty with appropriate vascu-
lar access creation for hemodialysis when necessary, and
should largely be discouraged [4].
Resource for researchers
The surveillance system was developed with help of prom-
inent clinician-scientists, epidemiologists and statisticiansinvolved in kidney disease research. To create the CKD
surveillance system, the CDC and their collaborators ana-
lyzed a number of data sources, and determined that no
one source would be adequate to create a surveillance
system for CKD [5]. Information from well-established
data sources were utilized for the surveillance system in-
cluding federal data (Center for Medicaid and Medicare
Services, U.S. Census); national registries [U.S. Renal Data
System (USRDS), National Health and Nutrition Survey
(NHANES), Scientific Registry for Transplant Recipients,
American Medical Association]; population-based and
prospective cohort studies (Chronic Renal Insufficiency
Cohort [6], Chronic Kidney Disease in Children [7], The
SEARCH for Diabetes in Youth Study [8], Atherosclerosis
Risk in Communities Study [9], Renal Reasons for
Geographical and Racial Difference in Stroke [10]); and
healthcare system data from the Veterans Health Admi-
nistration (VHA) system [11]. In this newly created cen-
tralized data repository, over 200 interactive charts and
figures are available to all researchers. What is particularly
unique to this system is the variety of ways in which the
burden of CKD is described; information is drawn not
only from general population sources such as NHANES
and USRDS, but from the VHA, a large health care sys-
tem. The information is reliable, regularly updated and
new measures and indicators are continually being deve-
loped. This website aims to be not only the most com-
prehensive source for background information paramount
to CKD research, but also to highlight areas of kidney dis-
ease that are lacking in evidence and in need of further
research.
There are a number of limitations of the present CKD
surveillance system. Although the surveillance system
draws from many established data sources, none of these
data sources were designed for the specific purpose of
CKD surveillance. In using the data from administrative
sources and cohort studies, the information is also
subjected to the inherent biases, such as lack of repre-
sentativeness, absence of longitudinal data, missing or
incomplete data, and diagnostic inaccuracies. Although
inclusion of health system data is unique and enriching,
the indicators described within the context of the VHA
system may not be representative of all health care sys-
tems. The initial intent was to have information from
private health care plans, however the creators purport
that it was difficult to enlist these sources because of
“privacy concerns, time and effort requirements, and
cost” [12]. Incorporation of information from the dif-
ferent data sources while improving the representa-
tiveness; creates uncertainty regarding the appropriate
denominator for the risk estimates, especially with re-
gard to the health system data. Other limitations cited in
the executive summary included difficulty getting un-
published data from investigators and having little to no
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rather than raw data, was provided [12].
Other national surveillance systems
The Kidney Disease Improving Global Outcomes (KDIGO)
task force periodically disseminates surveillance data from
other countries. These other surveillance systems vary
based on the country's health care policies and resources.
Some countries, similar to our national surveillance sys-
tem, rely heavily on established data sources and survey
data, while other countries may actively screen for kidney
disease and/or create active registries for patients with
CKD. However, all these surveillance systems share the
same objectives: quantifying the burden of disease; pro-
moting awareness; and implementing policies that will lead
to prevention and improved health care to patients with
kidney disease [13,14].
Conclusion
According to the CDC, the purpose of the Chronic Kidney
Disease Surveillance System is to “document the burden
of CKD and its risk factors in the U.S. population over
time and track the progress of our efforts to prevent, de-
tect, and manage CKD” [15]. Such a system is necessary
to promote public awareness and advance initiatives that
will lead to early detection and prevention, and ultimately
reduce the burden of CKD in the U.S. This website will
undoubtedly become a paramount resource for patients,
physicians, researchers, policy-makers and the public at
large.
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